PNP Therapeutics' Series E Round

PNP Therapeutics raised a round of funding on August 17, 2018. Investors include Greer Capital Advisors.

PNP Therapeutics is dedicated to the development and commercialization of a cancer treatment approach that is predicated on well-documented evidence that solid tumors can be compelled to develop their…

Articles about PNP Therapeutics' Series E Round: